Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference.

Published on Mar 8, 2021in Europace4.045
· DOI :10.1093/EUROPACE/EUAA279
Larissa Fabritz45
Estimated H-index: 45
(University of Birmingham),
Harry J.G.M. Crijns83
Estimated H-index: 83
(Maastricht University Medical Centre)
+ 55 AuthorsPaulus Kirchhof108
Estimated H-index: 108
(University of Birmingham)
AIMS The risk of developing atrial fibrillation (AF) and its complications continues to increase, despite good progress in preventing AF-related strokes. METHODS AND RESULTS This article summarizes the outcomes of the 7th Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA) held in Lisbon in March 2019. Sixty-five international AF specialists met to present new data and find consensus on pressing issues in AF prevention, management and future research to improve care for patients with AF and prevent AF-related complications. This article is the main outcome of an interactive, iterative discussion between breakout specialist groups and the meeting plenary. AF patients have dynamic risk profiles requiring repeated assessment and risk-based therapy stratification to optimize quality of care. Interrogation of deeply phenotyped datasets with outcomes will lead to a better understanding of the cardiac and systemic effects of AF, interacting with comorbidities and predisposing factors, enabling stratified therapy. New proposals include an algorithm for the acute management of patients with AF and heart failure, a call for a refined, data-driven assessment of stroke risk, suggestions for anticoagulation use in special populations, and a call for rhythm control therapy selection based on risk of AF recurrence. CONCLUSION The remaining morbidity and mortality in patients with AF needs better characterization. Likely drivers of the remaining AF-related proplems are AF burden, potentially treatable by rhythm control therapy, and concomitant conditions, potentially treatable by treating these conditions. Identifying the drivers of AF-related complications holds promise for stratified therapy.
📖 Papers frequently viewed together
64 Authors (Dipak Kotecha, ..., Paulus Kirchhof)
68 Citations
2 Citations
1 Citations
#1Janine Dretzke (University of Birmingham)H-Index: 19
#2Naomi Chuchu (University of Birmingham)H-Index: 16
Last. Yemisi Takwoingi (University of Birmingham)H-Index: 40
view all 11 authors...
AIMS: We assessed the performance of modelsf (risk scores) for predicting recurrence of atrial fibrillation (AF) in patients who have undergone catheter ablation. METHODS AND RESULTS: Systematic searches of bibliographic databases were conducted (November 2018). Studies were eligible for inclusion if they reported the development, validation, or impact assessment of a model for predicting AF recurrence after ablation. Model performance (discrimination and calibration) measures were extracted. Th...
15 CitationsSource
#1Emanuele BertagliaH-Index: 24
#2Benjamin F. BlankH-Index: 3
Last. Paulus Kirchhof (University of Birmingham)H-Index: 108
view all 20 authors...
Self-terminating atrial arrhythmias are commonly detected on continuous rhythm monitoring, e.g. by pacemakers or defibrillators. It is unclear whether the presence of these arrhythmias has therapeu ...
16 CitationsSource
#1Zachi I. Attia (Mayo Clinic)H-Index: 12
#2Peter A. Noseworthy (Mayo Clinic)H-Index: 45
Last. Paul A. Friedman (Mayo Clinic)H-Index: 69
view all 12 authors...
Summary Background Atrial fibrillation is frequently asymptomatic and thus underdetected but is associated with stroke, heart failure, and death. Existing screening methods require prolonged monitoring and are limited by cost and low yield. We aimed to develop a rapid, inexpensive, point-of-care means of identifying patients with atrial fibrillation using machine learning. Methods We developed an artificial intelligence (AI)-enabled electrocardiograph (ECG) using a convolutional neural network t...
238 CitationsSource
#1Andreas GoetteH-Index: 37
#2Angelo AuricchioH-Index: 80
Last. Frank R. Heinzel (Charité)H-Index: 30
view all 29 authors...
Clinicians accept that there are many unknowns when we make diagnostic and therapeutic decisions. Acceptance of uncertainty is essential for the pursuit of the profession: bedside decisions must often be made on the basis of incomplete evidence. Over the years, physicians sometimes even do not realize anymore which the fundamental gaps in our knowledge are. As clinical scientists, however, we have to halt and consider what we do not know yet, and how we can move forward addressing those unknowns...
20 CitationsSource
#1Winnie Chua (University of Birmingham)H-Index: 9
#2Christina Easter (University of Birmingham)H-Index: 3
Last. Larissa Fabritz (University of Birmingham)H-Index: 45
view all 16 authors...
Atrial fibrillation (AF) is caused by different mechanisms but current treatment strategies do not target these mechanisms. Stratified therapy based on mechanistic drivers and biomarkers of AF have the potential to improve AF prevention and management outcomes. We will integrate mechanistic insights with known pathophysiological drivers of AF in models predicting recurrent AF and prevalent AF to test hypotheses related to AF mechanisms and response to rhythm control therapy. We will harmonise an...
6 CitationsSource
#1Winnie Chua (University of Birmingham)H-Index: 9
#2Yanish Purmah (University of Birmingham)H-Index: 5
Last. Larissa Fabritz (University of Birmingham)H-Index: 45
view all 11 authors...
AIMS:Undetected atrial fibrillation (AF) is a major health concern. Blood biomarkers associated with AF could simplify patient selection for screening and further inform ongoing research towards stratified prevention and treatment of AF. METHODS AND RESULTS:Forty common cardiovascular biomarkers were quantified in 638 consecutive patients referred to hospital [mean ± standard deviation age 70 ± 12 years, 398 (62%) male, 294 (46%) with AF] with known AF or ≥2 CHA2DS2-VASc risk factors. Paroxysmal...
56 CitationsSource
#1Douglas L. Packer (Mayo Clinic)H-Index: 76
#2Daniel B. Mark (Duke University)H-Index: 136
Last. Kerry L. Lee (Duke University)H-Index: 139
view all 29 authors...
Importance Catheter ablation is effective in restoring sinus rhythm in atrial fibrillation (AF), but its effects on long-term mortality and stroke risk are uncertain. Objective To determine whether catheter ablation is more effective than conventional medical therapy for improving outcomes in AF. Design, Setting, and Participants The Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation trial is an investigator-initiated, open-label, multicenter, randomized trial involving 126...
394 CitationsSource
#1Carina Blomström-Lundqvist (Uppsala University)H-Index: 7
#1Carina Blomström-Lundqvist (Uppsala University)H-Index: 63
Last. David Mörtsell (Uppsala University)H-Index: 2
view all 12 authors...
Importance: Quality of life is not a standard primary outcome in ablation trials, even though symptoms drive the indication.Objective: To assess quality of life with catheter ablation vs antiarrhythmic medication at 12 months in patients with atrial fibrillation.Design, Setting, and Participants: Randomized clinical trial at 4 university hospitals in Sweden and 1 in Finland of 155 patients aged 30-70 years with more than 6 months of atrial fibrillation and treatment failure with 1 antiarrhythmic...
81 CitationsSource
#1William F. McIntyre (Population Health Research Institute)H-Index: 8
#1William F. McIntyre (UM: University of Manitoba)H-Index: 13
Last. Jeff S. Healey (Population Health Research Institute)H-Index: 77
view all 12 authors...
Objective:There is uncertainty about the incidence of and prognosis associated with atrial fibrillation that is documented for the first time in the setting of an acute stressor, such as surgery or medical illness. Our objective was to perform a systematic review of the incidence and long-term recurrence rates for atrial fibrillation occurring transiently with stress in the setting of acute medical illness.Data sources:Medline, Embase and Cochrane Central to September 2017.Study selection:We inc...
21 CitationsSource
#1Awni Hannun (Stanford University)H-Index: 18
#2Pranav Rajpurkar (Stanford University)H-Index: 19
Last. Andrew Y. Ng (Stanford University)H-Index: 12
view all 7 authors...
Computerized electrocardiogram (ECG) interpretation plays a critical role in the clinical ECG workflow1. Widely available digital ECG data and the algorithmic paradigm of deep learning2 present an opportunity to substantially improve the accuracy and scalability of automated ECG analysis. However, a comprehensive evaluation of an end-to-end deep learning approach for ECG analysis across a wide variety of diagnostic classes has not been previously reported. Here, we develop a deep neural network ...
687 CitationsSource
Cited By11
#1Renate B. SchnabelH-Index: 70
#2Larissa Fabritz (University of Birmingham)H-Index: 45
Last. Paulus Kirchhof (University of Birmingham)H-Index: 108
view all 3 authors...
1 CitationsSource
#1Peter Hämmerle (University Hospital of Basel)H-Index: 1
#2Stefanie Aeschbacher (University Hospital of Basel)H-Index: 19
Last. David Conen (Population Health Research Institute)H-Index: 48
view all 13 authors...
Atrial fibrillation (AF) is associated with loss of cognition and dementia. Cardiac autonomic dysfunction has been linked to cognitive decline. We aimed to investigate if reduced cardiac autonomic function (CAF) is associated with cognitive impairment in AF patients. Patients with paroxysmal, persistent and permanent AF were enrolled from a multicenter cohort study if they had AF (“AF group”) or sinus rhythm (“SR group”) on a baseline 5 min ECG recording. Parameters quantifying CAF (heart rate v...
#1Marco Vitolo (University of Modena and Reggio Emilia)H-Index: 6
#2Jacopo Francesco Imberti (University of Modena and Reggio Emilia)H-Index: 4
Last. Gregory Y.H. Lip (University of Liverpool)H-Index: 195
view all 11 authors...
Abstract null null Background null Atrial High Rate Episodes (AHRE) are asymptomatic atrial tachy-arrhythmias detected through continuous monitoring with a cardiac implantable electronic device. The risks of stroke/Thromboembolic (TE) events and incident clinical Atrial Fibrillation (AF) associated with AHRE varies markedly. null null null Objectives null To assess the relationship between AHRE and TE events, and between AHRE and incident clinical AF. null null null Methods null This systematic ...
#1Shinwan Kany (UHH: University of Hamburg)H-Index: 1
#2Bruno Reissmann (UHH: University of Hamburg)H-Index: 1
Last. Renate B. Schnabel (UHH: University of Hamburg)H-Index: 32
view all 6 authors...
The prevalence and economic burden of atrial fibrillation (AF) are predicted to more than double over the next few decades. In addition to anticoagulation and treatment of concomitant cardiovascular conditions, early and standardized rhythm control therapy reduces cardiovascular outcomes as compared with a rate control approach, favoring the restoration and maintenance of sinus rhythm safely. Current therapies for rhythm control of AF include anti-arrhythmic drugs (AAD) and catheter ablation (CA...
#1Julius Obergassel (University of Birmingham)
#2Molly O’Reilly (University of Birmingham)
Last. Larissa Fabritz (University of Birmingham)H-Index: 45
view all 9 authors...
AIMS Genetically altered mice are powerful models to investigate mechanisms of atrial arrhythmias, but normal ranges for murine atrial electrophysiology have not been robustly characterized. METHODS AND RESULTS We analyzed results from 221 electrophysiological (EP) studies in isolated, Langendorff-perfused hearts of wildtype mice (114 female, 107 male) from 2.5 to 17.7 months (mean 7 months) with different genetic backgrounds (C57BL/6, FVB/N, MF1, 129/Sv, Swiss agouti). Left atrial monophasic ac...
1 CitationsSource
#1Winnie Chua (University of Birmingham)H-Index: 9
#2Larissa Fabritz (University of Birmingham)H-Index: 45
Atrial fibrillation (AF) unabashedly retains the title of most commonly sustained cardiac arrhythmia worldwide.1 It is known as a major cause of stroke by increasing its risk fivefold. As a result of widespread clinical education and the advent of technologies which avail novel and safer anticoagulants, an increasing number of healthcare professionals and patients alike now have awareness of stroke prevention in AF. This is a huge success. However, as notably stated by Weber et al 2 in this issu...
#1Jordi Heijman (UM: Maastricht University)H-Index: 25
#2Kevin Vernooy (UM: Maastricht University)H-Index: 29
Last. Isabelle C. Van Gelder (UG: University of Groningen)H-Index: 83
view all 3 authors...
Atrial fibrillation (AF) can be a significant burden for patients as well as the health care system. Every third 55-year-old will develop AF. Despite improvements of disease management, a significant risk for cardiovascular events remains. The current AF guidelines of the European Society of Cardiology focus on an integrative therapy approach. The new algorithm "CC to ABC" comprises recommendations for diagnosis ("confirm" and "characterise") and treatment ("avoid stroke", "better symptom contro...